AzTrials
AzTrials

BurnoutReTA-modelNCT05314530

The ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare Sector

A study testing ReTA-model in people with Burnout, run by Karolinska Institutet at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. Read more about this study

Who is it for?
Any age
Conditions the study is for
Burnout
What is being tested?
ReTA-model
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteSweden
Study dates
1 Mar 2022to Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • currently on sick leave for burnout
  • employed in the Swedish healthcare services as a nurse or as a physician

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Emma Hagqvist, PhD contact

+46730526602

emma.hagqvist@ki.se

Åke Nygren, MD contact

Sweden1 site, 1 recruiting
  • Karolinska Institutet

    Stockholm, Outside U.S. and Canada, 171 77

    Emma Hagqvist, Phd, +46730526602, emma.hagqvist@ki.se

    Recruiting

Other trials in Sweden

About this study

Official title: Validation of the ReTA-model: Rehabilitation Trail for Workers on Long-term Sick Leave in the Healthcare

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Read the detailed description

The ReTA-model is a rehabilitation model for return to work after long-term sickness absence (LTSA) due to stress or burnout. The ReTA-model will be validated in this trial among nurses and physicians currently in LTSA. The ReTA-model includes a three-week treatment with exercise, individual and collegial talks with psychology and lecturing. The control group will receive conventional rehabilitation from regular care.

Conditions
Burnout
Being tested
ReTA-model
Keywords
Healthcare, Burnout, Stress, Return to work, Intervention
Medical subject headings
Burnout, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReTA-modelBehavioural

    Validating the rehabilitation model ReTA

Study groups in NCT05314530
Study groupRoleWhat they receive
Intervention groupExperimentalWill receive a rehabilitation intervention
Receives: Behavioral: ReTA-model
ControllActive comparatorWill receive conventional rehabilitation
Receives: Behavioral: ReTA-model

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Return to work

    At work part or full-time compare to no return to work

    Measured: 12 months

  2. Karolinska Exhaustion Disorder Scale KEDS

    Decreased points in the KEDS scale 1-19, qith higher scores reflecting greater exhaustion severity.

    Measured: 12 months

  3. Symptom Checklist - 6

    Decreased points on the SCL-6 scale, with a higher number reflecting depression.

    Measured: 12 months

  4. Montgomery Åsberg Depression Rating Scale

    Decreased points in the MADRAS scale with score ranging from 0 to 60, with higher scores reflecting greater depression severity.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2022
  2. Study start1 Mar 2022
  3. Primary completionApr 2023 (estimated)
  4. Study completionSep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05314530
Sponsor's protocol ID
ReTA-model
Acronym
ReTA-model
Status last verified
Mar 2022
First submitted
30 Mar 2022
Last updated
6 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Thunqvist E, Nygren A, Lofman B, Parker D, Brulin E. Assessing the Effect of a Rehabilitation Intervention on Exhaustion Disorders, Depression, and Return to Work: A Randomized Controlled Trial. J Occup Rehabil. 2025 Dec 13. doi: 10.1007/s10926-025-10350-y. Online ahead of print.

    PubMed 41389236

Questions about this trial

What is this clinical trial studying?

A study testing ReTA-model in people with Burnout, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Emma Hagqvist, PhD (+46730526602, emma.hagqvist@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Return to work (time frame: 12 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05314530, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in